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Gastrointestinal complications after descending
thoracic and thoracoabdominal aortic repairs:
A 14-year experience
Paul E. Achouh, MD, Ken Madsen, MD, Charles C. Miller III, PhD, Anthony L. Estrera, MD,
Ali Azizzadeh, MD, Jayesh Dhareshwar, MD, Eyal Porat, MD, and Hazim J. Safi, MD, Houston, Texas
Objective: There is a paucity of data regarding gastrointestinal (GI) complications after descending thoracic and
thoracoabdominal aortic (DTA/TAA) surgical repairs. We examined our 14-year experience with these repairs to
determine the incidence, outcomes, and risk factors for postoperative GI complications.
Methods: Between February 1991 and February 2005, we repaired 1159 DTA/TAA. Data were prospectively collected.
The mean patient age was 68 years and 36% were women. Complications were classified as biliary disease, hepatic
dysfunction, pancreatitis, GI bleeding, peptic ulcer disease, bowel ischemia, and ileus. Risk factors for the occurrence of
GI complications were ascertained by univariate and multivariable analysis.
Results: Of the 1159 patients, 81 had 109 GI complications, for a 7% incidence. The mortality associated with GI
complications was 39.5% compared with 13.5% (P < .0001) in patients without GI complications. The incidences of
complications were bowel ischemia, 2.5% with 62% mortality; biliary disease, 0.3% with 75% mortality; hepatic
dysfunction, 1.6% with 38% mortality; acute pancreatitis, 0.3% with 20% mortality; GI bleeding, 1.5% with 29%
mortality; peptic ulcer disease, 0.9% with 30% mortality; and ileus, 2.2% with 26% mortality. Postoperative biliary disease
(odds ratio [OR], 16.58; P  .001), hepatic dysfunction (OR, 3.58; P  .006), and bowel ischemia (OR, 10.03; P 
.0001) were significantly associated with an increased postoperative mortality. Risk factors for the occurrence of GI
complications were visceral involvement of the aortic repair (TAA extent II, III, and IV) (OR, 2.08; P  .002) and low
preoperative glomerular filtration rate (OR, .98; P  .0002).
Conclusion:Biliary disease, hepatic dysfunction, and bowel ischemia after DTA/TAA surgical repairs were associated with
an increasedmortality. Visceral involvement and preoperative renal insufficiency were risk factors for the occurrence of GI
complications. ( J Vasc Surg 2006;44:442-6.)Repair of the descending thoracic and thoracoabdomi-
nal aorta (DTA/TAA) remains a challenge. The use of
adjuncts has dramatically decreased the incidence of neu-
rologic deficit in the last decade.1,2 Other potentially seri-
ous complications, such as gastrointestinal (GI) complica-
tions, still need to be addressed, however. There is paucity
of data regarding the incidence of GI complications after
DTA/TAA surgery and their impact on postoperative out-
comes. A number of reports have addressed the issue of
specific GI complications after abdominal aortic repairs,
most commonly infrarenal procedures.3-5 These complica-
tions seem to be associated with higher postoperative mor-
bidity and mortality. We studied the incidence, risk factors,
and outcomes of postoperative GI complications in our
DTA/TAA surgical experience over 14 years.
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442METHODS
Between February 1991 and February 2005, we per-
formed 1159 repairs of the DTA/TAA. Data were col-
lected prospectively and reviewed retrospectively as ap-
proved by the Committee for the Protection of Human
Subjects at the University of Texas Houston Medical
School. The mean patient age was 68 years (range, 18 to 90
years) and 36% were women (417/1159). The extent of
the TAA repair was classified according to the modified
Crawford classification (Fig).6
Surgical technique. The details of our present surgi-
cal technique have been described previously1,2 and are
briefly reviewed here. After general anesthesia is induced,
the anesthesiologist inserts a cerebrospinal fluid (CSF)
drainage catheter into the third or fourth lumbar space.
CSF drainage is performed to maintain a CSF pressure of
10 mm Hg during the operation and postoperatively for
3 days. Neurologic monitoring includes electroencepha-
lography, somatosensory evoked potentials, and motor
evoked potentials.
The patient is positioned in the right lateral decubitus
position with the hips flexed 60° for accessibility to the left
and right groin. The incision is tailored to complement the
extent of the aortic repair. The diaphragm is preserved,
exposing only the aortic hiatus. After the patient is antico-
agulated with heparin (1 mg/kg), distal aortic perfusion is
established by cannulating the left common femoral artery
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(Medtronic, Minneapolis, Minn) with an in-line heat ex-
changer and an ice bath system is used for distal aortic
perfusion and visceral perfusion.
Aortic reconstruction involves sequential aortic cross-
clamping. For the proximal anastomosis, complete transec-
tion of the aorta is undertaken to separate it from the
underlying esophagus. Reattachment of patent lower inter-
costal arteries (T8 to T12) is performed routinely. With
completion of intercostal artery reattachment, the abdom-
inal aorta is opened and the visceral vessels are perfused
using 13F or 9F balloon-tipped catheters with blood or
crystalloid solution. Severe visceral and renal artery stenosis
are treated with individual bypasses or aortic endarterec-
tomy. Core body temperature is maintained between 32 °C
and 34 °C. The distal aortic perfusion and renal and visceral
perfusion pressures aremaintained60mmHg.Before com-
pletion of the distal anastomosis, the graft is flushed proxi-
mally and the aorta distally. The patient is weaned from partial
bypass once the core temperature has reached 36 °C. Prota-
mine is then administered and the atrial and femoral cannulae
are removed.
Study variables and definitions. Data regarding pa-
tient demographics, risk factors, operative details, and post-
operative course/complications were collected prospectively
and entered into a database. Preoperative renal function was
assessed by the glomerular filtration rate (GFR) using the
Cockroft-Gault formula.7
Gastrointestinal complications occurring in the 30-day
postoperative period were classified as biliary disease, he-
patic dysfunction, pancreatitis, GI bleeding, peptic ulcer
disease, bowel ischemia, and ileus.
Biliary disease was defined as the occurrence of acute
cholecystitis or acute biliary tract obstruction 30 postop-
Fig. Modified Crawford classification for the extent of the thora-
coabdominal aortic repair. Extent I, distal to the left subclavian
artery to above the renal arteries. Extent II, distal to the left
subclavian artery to below the renal arteries; this is the most
extensive type of aneurysm and the only extent that is still associ-
ated with risk of paraplegia, with the use of adjunct distal aortic
perfusion, cerebrospinal fluid drainage andmoderate hypothermia.
Extent III, from the sixth intercostal space to below the renal
arteries. Extent IV, from the 12th intercostal space to the iliac
bifurcation (total abdominal aortic aneurysm). Extent V, from
below the sixth intercostal space to just above the renal arteries.erative days. Clinical suspicion was confirmed by an abdom-inal ultrasound coupled with an abdominal computed
tomography (CT) scan. Final diagnosis was ultimately as-
certained by surgery.
Hepatic dysfunction was defined as clinical jaundice
associated with an elevation of hepatic enzymes more than
twice the normal levels with or without other signs of liver
failure.8
Acute pancreatitis was defined as an elevation of pan-
creatic enzymes (lipase and amylase) more than three times
the normal levels5 and a positive abdominal CT scan.
Bowel ischemia was identified by serial endoscopies and
CT scans; and, in most cases, ultimately confirmed at
surgery.
Peptic ulcer disease was defined as gastric or duodenal
ulcerations on endoscopy.
GI bleeding was defined as the presence of macroscopic
upper or lower GI bleeding and was routinely investigated
by endoscopy.
Ileus was defined as the absence of bowel activity after
the fifth postoperative day after ruling out mechanical
obstruction.3,9
Statistical analysis. Each GI complication was evalu-
ated individually by univariate contingency table analysis
for association with 30-day mortality. Separate risk factor
analyses were conducted for the two outcome variables of
GI complications and 30-daymortality. Data were analyzed
by contingency table and by univariate andmultiple logistic
regression analysis. Continuous data were divided into
quartiles for contingency table analysis. Categoric data
were arrayed as shown in Table I. Continuous data were
evaluated for normality and were subjected to univariate
logistic regression analysis in their continuous distribution
to confirm the contingency table results. After univariate
analysis, multivariable logistic regression analyses were con-
ducted using automated best-subsets model selection, fol-
lowed by manual forward-stepped model verification. All
computations were performed using SAS 9.1.3 service pack
4 (SAS Institute, Inc, Cary, NC).
RESULTS
GI complications occurred in 81 (7%) of the 1159 pa-
tients, and the incidence and associated mortalities are sum-
Table I. Incidence of gastrointestinal complications and
associated mortalities
GI complication
Incidence
N (%)
Associated 30-day mortality
N (%) OR P
Biliary disease 4 (0.3) 3 (75) 16.58 .001
Hepatic dysfunction 18 (1.6) 7 (38) 3.58 .006
Bowel ischemia 29 (2.5) 18 (62) 10.03 .0001
Pancreatitis 5 (0.3) 1 (20) 1.36 .79
GI bleeding 17 (1.5) 5 (29) 2.30 .11
Ileus 26 (2.2) 7 (26) 2.04 .11
Peptic ulcer disease 10 (0.9) 3 (30) 2.35 .21
GI, Gastrointestinal; OR, odds ratio.marized in Table I. More than one GI complication devel-
vailabl
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developed in seven (0.6%) patients. All four of the acute
cholecystitis were acalculous, and two were necrotic at sur-
gery. One of the five instances of acute pancreatitis was a
severe necrotic case with a fatal outcome. In the 17 patients
with GI bleeding, four patients each (24) were identified with
bowel ischemia and peptic ulcer disease. No etiology could be
found on endoscopy in nine of 17 patients.
The 30-day postoperative mortality was 32 (39.5%) of 81
in the patients with GI complications compared with 145
(13.5%) of 1078 in the patients without GI complications (P
 .0001). The mean length of stay for patients with GI
Table II. Risk factors for the occurrence of gastrointestin
Variable
Patients
N (%)
GI com
N
Overall 1159 (100.0) 81
Age
18-60 299 (25.8) 17
61-68 267 (23.0) 14
69-74 283 (24.4) 20
75-90 310 (26.8) 30
Female 422 (36.4) 25
Male 737 (63.6) 56
Current Smoking 378 (32.6) 35
No Smoking 781 (67.4) 46
COPD 399 (34.4) 27
No COPD 760 (65.6) 54
Acute dissection 53 (4.6) 2
Aneurysm 1106 (95.4) 79
Rupture 87 (7.5) 7
Intact 1072 (92.5) 74
Redo 84 (7.3) 7
Primary 1075 (92.7) 74
Visceral involvemente 506 (43.7) 49
No visceral involvement 653 (56.3) 32
Cross-clamp timef
18-32 414 (36.5) 26
33-44 290 (24.8) 32
45-63 251 (21.6) 16
64-261 253 (17.1) 7
Intra-op transfusiong
0-4 388 (33.5) 26
5-8 279 (24.1) 32
9-18 242 (20.9) 16
17-104 250 (21.5) 7
GFRh
1.5-48.6 222 (24.9) 24
48.7-65.2 223 (25.0) 13
65.3-91.4 224 (25.1) 8
91.5-121.1 223 (25.0) 4
GI, Gastrointestinal; OR, odds ratio; CI, confidence interval; COPD, chron
aThe incidence of GI complications for each subgroup of patients for a give
bOR computed using the logit method with a zero-cell correction. For dic
referent OR is equal to 1. For continuous data, the OR refers to the incr
continuous data are presented in quartiles, the OR are against the continuo
cThis reflects the units against which its companion OR is computed. CIs a
dProbability of a type I statistical error (common P value). Values withou
univariate logistic regression likelihood ratio P values.
eCrawford extent II, III or IV, with extension of the repair below the renal
fCross-clamp time is expressed in minutes. Data to cross-clamp time were c
gIntra-operative transfusion is expressed in units of packed red blood cells.
hGFR is expressed in mL/kg/min. Data sufficient to calculate GFR were acomplications was 19 days vs 14 days for patients without GIcomplications (P .15). Postoperative biliary disease, hepatic
dysfunction, and bowel ischemia were significantly associated
with a higher mortality (P .005).
Table II summarizes the predicted risk of GI complica-
tions according to the different preoperative and operative
factors on univariate analysis. On multivariate analysis, the
risk factors for the occurrence of GI complications were
visceral involvement of the aortic repair (TAA extent II, III,
and IV) and low preoperative GFR (Table III).
DISCUSSION
To our knowledge, this is the first report that defines
plication
ionsa
ORb 95% CIc Pd
1.02 .99-1.05 .14 (.10)
.77 .47-1.25 .29
1
1.63 1.03-2.58 .04
1
.95 .59-1.53 .83
1
.51 .12-2.13 .35
1
1.18 .53-2.65 .69
1
1.23 .55-2.76 .62
1
2.08 1.31-3.30 .002
1
1.01 1.00-1.02 0.03
) 0.04
0.98 0.97-0.99 .0015 (.0001)
)
) .98 .97-.99 .0002 (.0001)
tructive pulmonary disease; GFR, glomerular filtration rate.
able.
ous variables, the OR represents a test against a reference category whose
odds associated with a one-unit increase in the variable value. Although
iable.
-based.
ntheses are Pearson 2 probabilities. Probability values in parentheses are
es.
te only on 1113 patients.
e only on 892 patients.al com
plicat
(%)
(7.0)
(5.7)
(5.2)
(7.1)
(9.7)
(5.9)
(7.6)
(9.3)
(5.9)
(6.8)
(7.1)
(3.8)
(7.1)
(8.1)
(6.9)
(8.3)
(6.9)
(9.7)
(4.9)
(6.3)
(11.1
(6.4)
(2.8)
(6.7)
(11.5
(6.6)
(2.8)
(10.8
(5.8)
(3.6)
(1.8)
ic obs
n vari
hotom
ease in
us var
re test
t pare
arteri
omplethe incidence of GI complications after DTA/TAA surgery
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complications occurred in 7% of DTA/TAA surgical repairs
in our series. The incidence has been reported in the
literature to be as high as 21% after abdominal aortic
surgery with transperitoneal approach and 27% after rup-
tured abdominal aortic aneurysm surgery.3,10 Another ret-
rospective study reports a 34% incidence of GI complica-
tions after abdominal aortic surgery with visceral artery
involvement.11 The significantly higher incidence of com-
plications in this particular report was probably due to the
use of a clamp-and-sew technique used by the authors
without any visceral perfusion adjuncts.
Associated mortality from GI complications after dif-
ferent types of surgeries can vary from 16% to 67%.12-19
The occurrence of GI complications in our series increased
the 30-day postoperative mortality from 13.5% to 39.5%.
Similar increases in mortality have also been reported in
aortic surgery by several other authors.3,10,11
Bowel ischemia was the most frequent GI complication
in our series. Most of these patients had atherosclerotic
aneurysms, with a high risk of embolization secondary to
the manipulation of their aorta. Atherosclerotic aneurysms,
especially those involving the abdominal aorta, are also
often associated with severe atherosclerotic disease of the
mesenteric vasculature. The mesenteric blood flow would
thus be easily compromised during cross-clamp of the aorta
or during distal aortic perfusion. Although the visceral
arteries are being perfused during the cross-clamp of the
abdominal aorta and the real visceral ischemic time is
theoretically no more than a few minutes, there is no
certainty that this flow is sufficient. In addition, some of our
patients require the use of vasoconstrictors postoperatively
as part of our protocol to maintain a high spinal cord
perfusion pressure. The use of vasopressors might compro-
mise the perfusion to the visceral organs in patients who are
already severely atherosclerotic.
The etiology for the development of pancreatitis is
likely multifactorial, including trauma to pancreatic tissue
owing to operative dissection and retraction, hypoperfu-
sion, and atheroembolism secondary to the manipulation
of the aorta. The incidence of acute pancreatitis after TAA
surgery is 1.2% to 5% in the literature, with two thirds of the
cases being mild-to-moderate pancreatitis.4,5,20 Our rela-
tively lower 0.3% incidence of acute pancreatitis is because
28% of our patients were DTA repairs with no abdominal
involvement, and thus, the risk of pancreatic manipulation
Table III. Multiple logistic regression model/risk factors
for GI complications
Variable
Parameter
estimate
Adjusted
OR 95% CI P
Intercept 1.8945 .03
Visceral involvement .6630 1.94 1.07-3.52
GFR .0209 .98 .97-.99 .0002or ischemia was lower.Historically, postoperative pancreatitis is associated
with a 40% to 50% mortality.21-23 Although mild-to-
moderate postoperative pancreatitis is a benign disease
according to some authors,4 severe necrotic pancreatitis
may carry a 100% mortality.5 Our single case of severe
pancreatitis was fatal. Acute pancreatitis was not associated
with a higher mortality in our study because three of our
four cases were mild-to-moderate pancreatitis. Although
the patient in our series with severe pancreatitis died, we
cannot draw any conclusions on the mortality associated
with acute pancreatitis after DTA/TAA surgery.
Postoperative hepatic dysfunction is also multifactorial.
In addition to the ischemic and embolic operative insult,
other superimposed factors such as massive transfusion, low
cardiac output, vasopressors, medication hepatoxicity, and
sepsis play a determinant role. Hepatic dysfunction is fre-
quently part of a worsening cycle of complications, leading
to multiple organ failure and death. Predictably, hepatic
dysfunction was significantly associated with a higher mor-
tality in our patients.
Acute cholecystitis was associated with the highest
postoperative mortality in our series (75%). Most of the
acute cholecystitis patients were very sick, with pre-existing
abdominal symptoms related to their initial TAA surgery
and with subacute clinical presentation of their cholecysti-
tis. The delay in diagnosis, as well as other severe comor-
bidities associated with the acute cholecystitis in these
patients, might account for the higher mortality in these
patients. These results are consistent with other reports of
50% to 100% mortality from acute cholecystitis after ab-
dominal aortic surgery.3,10
Visceral involvement of the aortic repair is one of the
factors significantly associated with the occurrence of GI
complications in our series. Any TAA repair that includes
manipulation, cross-clamp, and ischemia to the visceral
aorta is associated with a higher incidence of GI complica-
tions.3,11 Renal insufficiency is also a well-known risk factor
in all types of surgery.24 We recently found that GFR, as
calculated by the formula of Cockcroft andGault, is a better
predictor of mortality after DTA/TAA repair than the
serum creatinine level.7 In our present series, low GFR
seemed to be also a predictor of postoperative GI compli-
cations, which is consistent with other reports.11
This study should be viewed with certain limitations.
Although data were collected prospectively, analysis was
retrospective and is associated with its inherent biases. In
addition, this study extends over a period of 14 years,
during which our surgical management of the disease has
evolved from the earlier era of clamp-and-sew technique to
the present use of adjuncts. Moreover, different adjuncts
and perfusion techniques have been applied, and the affect
on GI complications is difficult to analyze.
CONCLUSION
GI complications can occur after DTA/TAA surgical
repairs, and more frequently with repairs that involve the
visceral aorta, e.g. extents II, III and IV. Biliary disease,
hepatic dysfunction and bowel ischemia were associated
JOURNAL OF VASCULAR SURGERY
September 2006446 Achouh et alwith a significant higher mortality. Visceral involvement
and preoperative renal insufficiency evaluated by GFR were
independent risk factors for the occurrence of GI compli-
cations. A high index of suspicion and early diagnosis and
treatment are essential to decreasing the mortality associ-
ated with these complications.17-19
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